QualityDipStocks / Finance · Investment Managers
Cohen & Steers CNS
Outside our quality screen, so we don’t track its dips. It’s 13% below its 52-week high.
Outside our quality screen, 5% over its Market Value. No fair value estimate for now: the model’s result is too extreme to stand behind.
- Fair value est.
- n/a
- Market Value
- $71.06price +5%
- Off 52-wk high
- −13%
- Risk vs market
- Lowbeta 0.55
4 bullish · 4 bearish See why
Repriced or dip?
Dip: business intact
The price is 13% below its 52-week high (Aug 13), but the business held up: revenue growth rate +1.2 pts, shares outstanding more shares, each owns less, revenue +2.7%.
Some numbers held up (revenue growth rate +1.2 pts, shares outstanding more shares, each owns less, revenue +2.7%), others slipped (free cash flow −47.7%). The price is 13% below its 52-week high.
The price is 13% below its 52-week high, and the business changed too: free cash flow −47.7%.
Within 10% of its 52-week high, so there is no dip to judge yet.
The evidence 9 numbers, high vs now
- Revenue, last 12 months$584M → $600M (+2.7%)held up
- Revenue growth rate+7.4% → +8.6% a year (+1.2 pts)held up
- Earnings per share, 12 months$3.25 → $3.24 (−0.2%)about the same
- Free cash flow, 12 months$68M → $36M (−47.7%)changed
- Operating margin32.9% → 32.4% (−0.5 pts)about the same
- Shares outstanding+0.5% (more shares, each owns less)held up
- Stock vs its sector (Finance)stock −13%, sector median −5% since Aug 13held up
- Price fall vs business numbersprice −13%, revenue/EPS/FCF median 0% (shown, not scored)
- Valuation multipleP/FCF 65.0× at the high → 108.4× now (shown, not scored)
Business numbers as reported at the high (12 months to Jun 30, 2026) vs the latest filing (12 months to Sep 30, 2026). Each measure is scored from −1 (business changed) to +1 (business intact) and weighted: revenue, earnings per share, free cash flow, operating margin, revenue growth rate, share count, net cash and the move vs its sector. 60 or more reads as a dip, 40 or less as a repricing. Analyst estimates are not in our data, so they are not used. How to read it
Data-based read, not advice.
Priced in
How much growth the market assumed at the 52-week high, the low and today (a reverse DCF).
At the high ($85.65, Aug 13) the price assumed about 29%/yr free-cash-flow growth; today about 39%. The last 3 years delivered −1%/yr (revenue).
Dashed line: what the last 3 years delivered, −1%/yr (revenue)
| High | Low | Now | |
|---|---|---|---|
| Price | $85.65Aug 13 | $59.24Nov 18 | $74.38 |
| Implied growth | +29% | n/a | +39% |
| P/E | 26.4× | 18.6× | 23.0× |
| P/FCF | 65.0× | — | 108.4× |
What this means: the higher the implied growth, the more the price already counts on. If today's number sits well below what the business has delivered, the market expects less than its track record.
How it’s computed
Reverse DCF: the same 10-year free-cash-flow model as our fair value estimate (9.5% discount rate, growth for years 1–5 fading to 3% by year 10, 3% after), solved for the growth that makes it equal the market value at each price. For the high and the low we use only the filings that were public on that day, so nothing from a later report leaks back. Market value = that close × diluted shares. P/E = market value / 12-month net income; Price / FCF = market value / 12-month free cash flow; EV / Sales = (market value + debt − cash) / 12-month revenue. Hidden when the share count moved over 20% (split, merger), free cash flow is negative, or the company reports in another currency.
Valuation
What we estimate it's worth, and how it ranks on value vs every stock we cover.
Fair value estimate
Estimate unreliable for CNS: the model gives 85% below the price; trailing free cash flow is small next to the company's value, so a DCF on it says little. We’d rather show nothing than a made-up number.
What the price implies To be worth today’s price, CNS’s free cash flow would need to grow about 39% a year for five years; our estimate uses 3%.
Risk vs market
How risk vs market is measured
One year of daily returns (Oct 31 to Nov 2, 252 sessions). Beta = how much CNS moved for each 1% move in the S&P 500 (SPY); 1.0 moves with the market. Volatility is the yearly standard deviation of daily returns. Past behavior, not a forecast.
Moves much less than the market, but its own price swings are 2.2× the S&P 500’s (it moves on its own news).
- Beta vs S&P 500
- 0.55
- Volatility
- 28% vs 13% SPY
- Correlation SPY
- 0.25
- Correlation QQQ
- 0.09
Valuation details
MV $71.06 · FCF value $19.57
Fundamentals
The business itself: sales, profits, cash and debt, from SEC filings.
Bull vs bear
Rule-based from the data on this page, strongest first. Not advice.
Top bullish points 4 of 5
ProfitabilityReturn on equity of 29% over the last 12 months.
ProfitabilityOperating margin of 32% over the last 12 months.
Cash returnsDividend yield of 3.5% ($135M paid over 12 months, 80% of earnings).
GrowthSales grew 9% to $600M over the last 12 months vs the 12 months before (SEC filings).
Top bearish points 4 of 5
ValuationFree-cash-flow yield is just 0.9% (price / FCF 108×), so the price leans on future growth.
ProfitabilityReturn on equity fell 7 points in two fiscal years, to 27% in FY2025.
GrowthSales fell 0.6% a year over the last three fiscal years, below the 9.2% median for the 286 Finance companies we cover.
Cash returnsDividends take 80% of earnings ($135M paid over 12 months), leaving little to reinvest or raise the payout.
All fundamentals
P/E 23.0 · FCF yield 0.9% · ROE 29%
Valuation
- P/E
- 23.0×Finance median 13.6×
- Price / FCF
- 108.4×
- FCF yield
- 0.9%
- EV / EBITDA
- n/aD&A or debt not tagged in SEC data
- Price / sales
- 6.46×
- Price / book
- 6.38×
- Market cap
- $3.9Bprice × diluted shares
- Enterprise value
- n/anot reported in its SEC filings
Growth
- Revenue, 12 months
- $600M
- Sales growth, 12 months
- +8.6%vs the 12 months before
- Sales growth, 3 yrs
- −0.6%/yrfrom FY2022
- Diluted EPS, 12 months
- $3.25
- EPS growth, last FY
- 0.0%
- Net income, 12 months
- $169M
- Net income growth
- +3%12 months vs before
Profitability
- Gross margin
- n/agross profit isn't reported (common for service and financial companies)
- Operating margin
- 32.4%
- Net margin
- 28.2%
- FCF margin
- 6.0%
- Return on equity
- 29%
- Return on invested capital
- n/aoperating income, debt, equity or cash not tagged
Balance sheet
- Cash & short-term inv.
- $66M
- Total debt
- n/anot reported in its SEC filings
- Net cash
- n/acash or debt not tagged in SEC data
- Debt / equity
- n/adebt or equity not tagged in SEC data
- Interest coverage
- n/ainterest expense not tagged in SEC data
Cash flow & returns
- Free cash flow, 12 months
- $36M
- FCF growth, 12 months
- n/anot reported in its SEC filings
- Dividend yield
- 3.49%$135M paid
- Payout ratio
- 80%
- Buybacks, 12 months
- $19M0.5% of market cap
- Share count, 1 year
- +1.1%diluted shares vs a year ago
- Stock-based comp
- $43M
Trailing 12 months to Sep 30, 2026; balance sheet at Sep 30, 2026. From Cohen & Steers’s SEC filings. Sparklines show up to six fiscal years. n/a means we don’t hold that number, with the reason. How each is computed.
The business
FCF $0.0B · Sales +11%
- Free cash flow, 12 months$0.0B
- Free-cash-flow yield0.9%
- Gross margin47%
- Operating margin32%
- Return on invested capital38%
- Return on equity25%
- Sales growth (latest quarter vs year-ago quarter)+11%
- Net debt / EBITDA−1.0×
Chart & levels
Where the price is vs its key levels and trends.
Key levels
Every level vs today’s $74.38
- 52-wk lowlowest close, 1 year$59.24−20.4%
- Market Valueavg paid since Oct 15$71.06−4.5%
- PriceMon Nov 2 close$74.38you are here
- 52-wk highhighest close, 1 year$85.65+15.2%
Momentum & 52-week range
RSI 58 · 5 days +4.6%
Signals
Reversal signal setups, the public ledger and the next earnings date.
Setup & signals
No setup armed
No setup armed, so there’s no trigger or stop to track yet. Reversal signal rules only run on companies that pass our quality screen.
CNS is outside our quality screen
One text when a published rule fires on one of the 332 quality companies we track: the ticker, the price, the stop and a link to the numbers. Nothing else.
Voices & buzz
Who is talking about it, and how it compares with peers.
Who’s talking about it
Notable investors, executives, analysts and public figures on Cohen & Steers in the last 48 hours. Headlines as published, each linked. Their words, not ours.
No notable mentions in the last 48 hours. Checked Nov 3, 1:01 PM ET.
Compare with peers
Closest in size in Investment Managers
Information only, not investment advice. Fair value estimates and talking points are rule-based model output from public data and can be wrong; stop levels are reference points, not orders. How every number is computed.